Skip to content
Tenfell
Awarded contract
Published 24 Apr 2026

NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

NHS England · London

Key facts

Awarded
27 Mar 2026
Contract starts
30 Apr 2026
Contract ends
30 Sep 2027
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 6 suppliers

SupplierValue
Celix Pharma Ltd.—
Dr Reddy's Laboratories (UK) Ltd—
Reig Jofre UK—
Accord-UK Ltd—
Zentiva Pharma UK Ltd—
Milpharm Limited—

Description

Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026 Offer reference number: CM/TNS/25/5736 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/25/5736 Nintedanib and Dalbavancin Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months) Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months) Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.